Luciana C. Ribeiro

Campinas, RS, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

SARS-CoV-2 uses CD4 to infect T helper lymphocytes.

SARS-CoV-2 uses CD4 to infect T helper lymphocytes.

Journal: eLife

Published: November 30, 2022

Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019.

Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019.

Journal: Frontiers in cardiovascular medicine

Published: January 03, 2022

Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19.

Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19.

Journal: Blood advances

Published: November 22, 2021

Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin-Kallikrein System in Severe COVID-19.

Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin-Kallikrein System in Severe COVID-19.

Journal: Viruses

Published: January 05, 2021

Rapid clinical recovery of a SARS-CoV-2 infected common variable immunodeficiency patient following the infusion of COVID-19 convalescent plasma.

Rapid clinical recovery of a SARS-CoV-2 infected common variable immunodeficiency patient following the infusion of COVID-19 convalescent plasma.

Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Published: September 30, 2020

Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis.

Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis.

Journal: Cell metabolism

Published: September 03, 2020

Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial.

Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial.

Journal: Trials

Published: June 10, 2020

Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis.

Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis.

Journal: Cell metabolism

Published: May 18, 2020

Showing 1-8 of 8

Last Updated: 09/26/2026